PI
ARCT icon

Putnam Investments’s Arcturus Therapeutics ARCT Stock Holding History

Putnam Investments’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$1.83M Sell
58,006
-1,839
-3% -$43.7K ﹤0.01% 769
2023
Q3 		$1.53M Sell
59,845
-5,192
-8% -$160K ﹤0.01% 771
2023
Q2 		$1.87M Buy
+65,037
New +$1.77M ﹤0.01% 748

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Putnam Investments's ARCT Position: Q4 2023 in Review

Putnam Investments reduced its Arcturus Therapeutics (ARCT) stake by 3.1% in Q4 2023, selling an estimated $43.7K and leaving 58,006 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #769.

Putnam Investments first reported a position in ARCT in Q2 2023 and has held it in 3 quarters since. The position peaked at $1.87M in Q2 2023. 165 funds tracked by Wall St. Rank hold ARCT as of Q4 2023.

  • Putnam Investments held 58,006 shares of Arcturus Therapeutics worth $1.83M as of Q4 2023.
  • Putnam Investments sold 1,839 Arcturus Therapeutics shares in Q4 2023, an estimated $43.7K.
  • Arcturus Therapeutics made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #769 holding.
  • Putnam Investments first reported a position in Arcturus Therapeutics in Q2 2023 and has held it in 3 quarters since.
  • Putnam Investments's Arcturus Therapeutics position peaked at $1.87M in Q2 2023.
  • 165 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.